About Thomson Reuters Recap
Informing key biopharmaceutical decisions
Thomson Reuters Recap's mission is to provide analysis and advice for biopharmaceutical business development. Recap's clients include biotechnology and pharmaceutical companies, universities, investment banking, and venture firms. More than 1,500 organizations utilize Recap's data services.
Recap was originally founded in 1988 and is now a subsidiary of Thomson Reuters. Bringing Recap into Thomson Reuters, and integrating it with the best-in-class coverage of industry R&D intelligence in Cortellis, solidifies Thomson Reuters as the leading provider of intelligence for the life sciences Business Development and Licensing market. The integrated offering provides customers with a single source of insight allowing them to more quickly and reliably ensure that they are finding the right partnership opportunities, and that they are structuring the deal terms that maximize the value those partnerships contribute to their business.